Research Topics
| Jean BousquetSummaryCountry: France Publications
| Collaborators
|
Detail Information
Publications
Predicting response to omalizumab, an anti-IgE antibody, in patients with allergic asthmaJean Bousquet
Service de Pneumologie, Hopital Arnaud de Villeneuve, Montpellier, France
Chest 125:1378-86. 2004..To determine baseline characteristics predictive of response to omalizumab, an anti-IgE antibody, in patients with allergic asthma...
The public health implications of asthmaJean Bousquet
Clinique des Maladies Respiratoires, Hopital Arnaud de Villeneuve, CHU Montpellier, 34295 Montpellier cedex 05, France
Bull World Health Organ 83:548-54. 2005..This paper presents a discussion of the burden of asthma and its socioeconomic implications and proposes a model to predict the costs incurred by the disease...
Severity and impairment of allergic rhinitis in patients consulting in primary careJean Bousquet
University Hospital and Institut National de la Santé et de la Recherche Médicale U454, Montpellier, France
J Allergy Clin Immunol 117:158-62. 2006..Allergic rhinitis is a disease impairing quality of life, sleep, and work. A new classification for allergic rhinitis, Allergic Rhinitis and its Impact on Asthma (ARIA), has recently been proposed...
Characteristics of intermittent and persistent allergic rhinitis: DREAMS study groupJ Bousquet
University Hospital and INSERM U454, Montpellier, France
Clin Exp Allergy 35:728-32. 2005..In the Allergic Rhinitis and its Impact on Asthma (ARIA) classification, intermittent and persistent rhinitis were proposed to replace seasonal and perennial allergic rhinitis (AR)...
Implementation of guidelines for allergic rhinitis in specialist practices. A randomized pragmatic controlled trialJean Bousquet
University Hospital and INSERM U780, Montpellier, France
Int Arch Allergy Immunol 150:75-82. 2009..Guidelines for allergic rhinitis are more effective than free-treatment choice in the control of seasonal allergic rhinitis...
A randomized, double-blind, double-dummy, single-dose, crossover trial evaluating the efficacy and safety profiles of two dose levels (12 and 24 microg) of formoterol-HFA (pMDI) vs. those of a dose level (24 microg) of formoterol-DPI (Foradil/Aerolizer) aJ Bousquet
Hopital Arnaud de Villeneuve, Montpellier, France
Respiration 72:13-9. 2005..These formulations contain hydrofluoroalkanes (HFAs) in redesigned metered-dose inhalers...
Effect of smoking on symptoms of allergic rhinitisPhilippe J Bousquet
University Hospital and INSERM U780, Montpellier, France
Ann Allergy Asthma Immunol 103:195-200. 2009..Tobacco smoking is common in patients with allergic rhinitis...
Natural rubber latex allergy among health care workers: a systematic review of the evidenceJean Bousquet
Service des Maladies Respiratoires, INSERM U454, Hopital Arnaud de Villeneuve, University Hospital, 34295 Montpellier Cedex 5, France
J Allergy Clin Immunol 118:447-54. 2006..Natural rubber latex is a recognized allergen, but a recent meta-analysis failed to find any association between latex exposure and allergy in health care workers (HCWs)...
Pilot study assessing the impact of smoking on nasal-specific quality of lifeP J Bousquet
Clinique des Maladies Respiratoires, , 34295- Montpellier-Cedex 05, France
Allergy 59:1015-6. 2004
A meta-analysis of the dose-response relationship of inhaled corticosteroids in adolescents and adults with mild to moderate persistent asthmaJean Bousquet
Service des Maladies Respiratoires, Hopital Arnaud de Villeneuve, Centre Hospitalier Universitaire Montpellier, France
Clin Ther 24:1-20. 2002..Although inhaled corticosteroids (ICS) are commonly used in the treatment of persistent asthma, the relationship between dose and clinical response remains unclear...
Predicting and evaluating response to omalizumab in patients with severe allergic asthmaJ Bousquet
Service de Pneumologie, Hopital Arnaud de Villeneuve, 371 Avenue du Doyen G Giraud, Montpellier 34295, France
Respir Med 101:1483-92. 2007..Omalizumab is a monoclonal antibody indicated for treatment of severe persistent allergic asthma inadequately controlled despite optimal controller therapy. We investigated whether patient selection could be targeted further...
[Nasal allergy and asthma: one or two diseases?]Pascal Demoly
Maladies Respiratoires, INSERM U454, IFR3, Hopital Arnaud de Villeneuve, CHU de Montpellier, 34295 Montpellier cedex 05
Bull Acad Natl Med 189:1461-73. 2005....
How to design and evaluate randomized controlled trials in immunotherapy for allergic rhinitis: an ARIA-GA(2) LEN statementJean Bousquet
University Hospital, Hopital Arnaud de Villeneuve, Montpellier, France
Allergy 66:765-74. 2011..It also provides some suggestions for the research that will be needed. Interestingly, some of the research questions can be approached with the available data obtained from large RCTs...
Severe asthma is associated with a loss of LX4, an endogenous anti-inflammatory compoundIsabelle Vachier
Clinique des Maladies Respiratoires, CHU, Montpellier, France
J Allergy Clin Immunol 115:55-60. 2005..Lipoxin production involves interaction between lipoxygenases, whereas 15-epi-lipoxin production might involve CytP450 activity...
Unmet needs in severe chronic upper airway disease (SCUAD)Jean Bousquet
University Hospital, Montpellier, France
J Allergy Clin Immunol 124:428-33. 2009..This document can also serve to optimize the pharmacoeconomic evaluation of SCUADs by means of comparison with mild chronic upper airway diseases...
Effects of inhaled corticosteroids on pathology in asthma and chronic obstructive pulmonary diseasePascal Chanez
Clinique des Maladies Respiratoires, Hopital Arnaud de Villeneuve, 371 Avenue du Doyen Gaston Giraud, 34295 Montpellier Cedex 5, France
Proc Am Thorac Soc 1:184-90. 2004..The effects of these drugs on structural changes in COPD have not been investigated extensively. Long-term prospective studies are needed to demonstrate the potential for ICSs to affect the natural history of chronic bronchial diseases...
Budesonide/formoterol for maintenance and relief in uncontrolled asthma vs. high-dose salmeterol/fluticasoneJean Bousquet
Hopital Arnaud de Villeneuve, 371 Avenue Doyen Gaston Giraud, FR 34000 Montpellier, France
Respir Med 101:2437-46. 2007....
Rapid effects of dexamethasone on intracellular pH and Na+/H+ exchanger activity in human bronchial epithelial cellsValia A Verrière
INSERM U454, Centre Hospitalier Universitaire Arnaud de Villeneuve, 34295 Montpellier, France
J Biol Chem 280:35807-14. 2005....
Establishing the place in therapy of bilastine in the treatment of allergic rhinitis according to ARIA: evidence reviewJean Bousquet
University Hospital, Department of Respiratory Diseases, Hopital Arnaud de Villeneuve, Montpellier, France
Curr Med Res Opin 28:131-9. 2012..Several criteria should be met by oral H(1)-antihistamines in terms of their pharmacological, and clinical efficacy and safety profiles...
Efficacy of desloratadine in persistent allergic rhinitis - a GA²LEN studyJean Bousquet
University Hospital, Hopital Arnaud de Villeneuve, Montpellier, France
Int Arch Allergy Immunol 153:395-402. 2010..There had been no placebo-controlled, randomized, clinical trial of desloratadine (DL) in patients with persistent allergic rhinitis to date...
Systemic exposure and implications for lung deposition with an extra-fine hydrofluoroalkane beclometasone dipropionate/formoterol fixed combinationJean Bousquet
University of Montpellier, Montpellier, France
Clin Pharmacokinet 48:347-58. 2009....
The Consolidated Standards of Reporting Trials (CONSORT) Statement applied to allergen-specific immunotherapy with inhalant allergens: a Global Allergy and Asthma European Network (GA(2)LEN) articlePhilippe J Bousquet
Department of Respiratory Diseases, University Hospital of Montpellier, Montpellier, France
J Allergy Clin Immunol 127:49-56, 56.e1-11. 2011..Randomized trials provide evidence to inform treatment decisions. The Consolidated Standards of Reporting Trials (CONSORT) Statement is a set of recommendations for the reporting of trials...
Change in visual analog scale score in a pragmatic randomized cluster trial of allergic rhinitisPhilippe Jean Bousquet
Service des Maladies Respiratoires, Hopital Arnaud de Villeneuve, Montpellier, France
J Allergy Clin Immunol 123:1349-54. 2009..Most patients with allergic rhinitis consult in primary care. A simple test is needed to evaluate globally the severity of allergic rhinitis to assess the efficacy of treatment...
High levels of urinary leukotriene E4 excretion in steroid treated patients with severe asthmaIsabelle Vachier
Clinique des Maladies Respiratoires, INSERM U454, , 371 Av du Doyen Gaston Giraud, 34295 Montpellier 5, France
Respir Med 97:1225-9. 2003..The findings support previous indications that one important component in asthmatic airway inflammation, the cysteinyl-leukotriene pathway remains relatively unopposed by oral glucocorticoids...
Montelukast in guidelines and beyondJean Bousquet
Service des Maladies Respiratoires, Hopital Arnaud de Villeneuve, 371 Avenue Doyen Gaston Giraud, 34275 Montpellier, Cedex 5, France
Adv Ther 26:575-87. 2009..This review includes new studies that have not yet been considered in guidelines...
Lipoxin A4 stimulates a cytosolic Ca2+ increase in human bronchial epitheliumCaroline Bonnans
INSERM U454, Department of Respiratory Disease, Centre Hospitalier Universitaire Arnaud de Villeneuve, 34295 Montpellier cedex 05, France
J Biol Chem 278:10879-84. 2003....
Immunotherapy: clinical trials--optimal trial and clinical outcomesPhilippe Jean Bousquet
Clinique des Maladies Respiratoires, Hopital Arnaud de Villeneuve, Centre Hospitalier Universitaire, Montpellier, France
Curr Opin Allergy Clin Immunol 7:561-6. 2007..Although specific immunotherapy was introduced a century ago, very few trials meet the criteria for pivotal studies. The paper reviews the methods which should be used to investigate specific immunotherapy...
Biologics in asthma: difficulties and drawbacksJean Bousquet
Hopital Arnaud de Villeneuve, Service des Maladies Respiratoires, 34295 Montpellier, Cedex 05, France
Expert Opin Biol Ther 8:1921-8. 2008..Biologics have become an increasingly important class of therapeutic compounds in a variety of immune and/or inflammatory diseases. Patients with severe uncontrolled asthma represent a significant unmet need...
Primary and secondary prevention of allergy and asthma by allergen therapeutic vaccinesJean Bousquet
Montpellier University, Montpellier, France
Clin Allergy Immunol 18:105-14. 2004
Inhaled corticosteroid/long-acting β₂-agonist combination therapy for asthma: attitudes of specialists in EuropeJean Bousquet
Clinic for Respiratory Diseases, Hopital Arnaud de Villeneuve, Montpellier, France
Int Arch Allergy Immunol 157:303-10. 2012..The aim of this study was to assess which attributes of combination therapy physicians consider most important...
The relation between asthma and allergic rhinitisPascal Demoly
Exploration des Allergies-Maladies Respiratoires-INSERM U454, , University Hospital of Montpellier, 34295 Montpellier Cedex 5, France
Lancet 368:711-3. 2006
Influence of sociodemographic factors on quality of life during pollen season in seasonal allergic rhinitis patientsLaurent Laforest
Pharmacoepidemiology Unit, EA 3091, University Hospital, Lyon, France
Ann Allergy Asthma Immunol 95:26-32. 2005..These factors must be taken into account when interpreting QOL of patients with SAR. Further studies are needed to confirm these results...
Development and implementation of guidelines in allergic rhinitis – an ARIA-GA2LEN paperJean Bousquet
University Hospital, Hopital Arnaud de Villeneuve, Montpellier Cedex 5, France
Allergy 65:1212-21. 2010..Guidelines must be updated as new management options become available or important new evidence emerges. Transparent reporting of guidelines facilitates understanding and acceptance, but implementation strategies need to be improved...
Uniform definition of asthma severity, control, and exacerbations: document presented for the World Health Organization Consultation on Severe AsthmaJean Bousquet
University Hospital, Hopital Arnaud de Villeneuve, Montpellier, France
J Allergy Clin Immunol 126:926-38. 2010..The last group includes asthma for which control is not achieved despite the highest level of recommended treatment and asthma for which control can be maintained only with the highest level of recommended treatment...
Drug provocation tests in patients with a history suggesting an immediate drug hypersensitivity reactionDjamel Messaad
Hopital Arnaud de Villeneuve, Montpellier, France
Ann Intern Med 140:1001-6. 2004..CONCLUSIONS: Drug provocation tests in individuals with suspected drug allergy performed in carefully controlled settings can confirm drug hypersensitivity...
Allergen immunotherapy: therapeutic vaccines for asthmaJean Bousquet
Montpellier University, Montpellier, France
Clin Allergy Immunol 18:511-28. 2004
[Identifying and understanding drug allergies]Pascal Demoly
Inserm U 454 IFR3, Hopital Arnaud de Villeneuve, Avenue Gaston Giraud, 34295 Montpellier, France
Med Sci (Paris) 19:327-36. 2003....
Allergy and asthma: from the bedside to the bench and international actionsJean Bousquet
Service des Maladies Respiratoires, INSERM, Hopital Arnaud de Villeneuve, Montpellier Cedex 05, France
Pol Arch Med Wewn 118:363-6. 2008..From research, public health programs can be designed...
Lipoxins are potential endogenous antiinflammatory mediators in asthmaCaroline Bonnans
Clinique des Maladies Respiratoires, INSERM U454-IFR 3, CHU, Montpellier, France
Am J Respir Crit Care Med 165:1531-5. 2002..Moreover, pertussis toxin reversed LXA4- and LXB4-inhibited IL-8 release. These findings suggest that lipoxins have potential antiinflammatory action in asthma...
Allergic rhinitis: a disease remodeling the upper airways?Jean Bousquet
Clinique des Maladies Respiratoires, University Hospital and INSERM U454, Montpellier, France
J Allergy Clin Immunol 113:43-9. 2004..A better understanding of nasal and bronchial remodeling might help to identify new pathways and new therapeutic strategies to reduce long-term remodeling in asthma...
Identifying 'well-controlled' and 'not well-controlled' asthma using the Asthma Control QuestionnaireElizabeth F Juniper
Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Canada
Respir Med 100:616-21. 2006....
Inhaled corticosteroids effects on bone in asthmatic and COPD patients: a quantitative systematic reviewFlorent Richy
WHO Collaborating Center for Public Health Aspects of Osteoarticular Disorders, Liege, Belgium
Osteoporos Int 14:179-90. 2003..These findings could have practical implication in the long-term management of asthmatic and COPD patients...
Meta-analysis: effects of adding salmeterol to inhaled corticosteroids on serious asthma-related eventsEric Bateman
Division of Pulmonology, Department of Medicine, University of Cape Town, Cape Town, South Africa
Ann Intern Med 149:33-42. 2008..Recent analyses have suggested an increased risk for serious asthma-related adverse events in patients receiving long-acting beta-agonists...
Rhinitis and onset of asthma: a longitudinal population-based studyRafea Shaaban
Unit 700 Epidemiology, National Institute of Health and Medical Research INSERM, Paris, France
Lancet 372:1049-57. 2008..We used the follow-up data from the European Community Respiratory Health Survey to investigate the onset of asthma in patients with allergic and non-allergic rhinitis during an 8.8-year period...
Association between asthma and rhinitis according to atopic sensitization in a population-based studyBenedicte Leynaert
INSERM Unité 408, Paris, France
J Allergy Clin Immunol 113:86-93. 2004..Although asthma and rhinitis often occur together, the reason for this common comorbidity is still a matter of debate...
The anti-inflammatory effects of omalizumab confirm the central role of IgE in allergic inflammationStephen Holgate
RCMB Research Division, Southampton General Hospital, United Kingdom
J Allergy Clin Immunol 115:459-65. 2005....
Quality of life during pollen season in patients with seasonal allergic rhinitis with or without asthmaLaurent Laforest
Pharmacoepidemiology Unit, EA3091 CHU Lyon-Sud, , France
Int Arch Allergy Immunol 136:281-6. 2005..At pollen peak, AS+SAR patients experienced significantly worse physical functioning than patients with SAR alone...
Improvement of aspirin-intolerant asthma by montelukast, a leukotriene antagonist: a randomized, double-blind, placebo-controlled trialSven Erik Dahlen
Experimental Asthma and Allergy Research, The National Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden
Am J Respir Crit Care Med 165:9-14. 2002..Addition of a leukotriene receptor antagonist such as montelukast improves asthma in aspirin-intolerant patients over and above what can be achieved by glucocorticosteroids...
Sensitisation to airborne moulds and severity of asthma: cross sectional study from European Community respiratory health surveyMahmoud Zureik
European Community Respiratory Health Survey, Unit 408 Epidémiologie, Faculte de Medecine Xavier Bichat, BP 416, 75870 Paris Cedex 18, France
BMJ 325:411-4. 2002..To assess whether the severity of asthma is associated with sensitisation to airborne moulds rather than to other seasonal or perennial allergens...
Allergic rhinitis and its consequences on quality of sleep: An unexplored areaDamien Leger
Centre du Sommeil et de la Vigilance de l Hôtel Dieu, Assistance Publique Hopitaux de Paris, Paris, France
Arch Intern Med 166:1744-8. 2006..The objective of our study was to assess, in patients with AR, whether duration and severity of AR are associated with sleep impairment...
Levocetirizine improves quality of life and reduces costs in long-term management of persistent allergic rhinitisClaus Bachert
Department of Oto Rhino Laryngology, University Hospital, Ghent, Belgium
J Allergy Clin Immunol 114:838-44. 2004..The Xyzal in Persistent Rhinitis Trial is the first large, long-term clinical trial studying patients with persistent rhinitis as defined by Allergic Rhinitis and its Impact on Asthma...
Allergic rhinitis, rhinosinusitis, and asthma: one airway diseaseClaus Bachert
ENT Department, Ghent University Hospital, De Pintelaan 185, 9000 Ghent, Belgium
Immunol Allergy Clin North Am 24:19-43. 2004
Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma ControL studyEric D Bateman
UCT Lung Institute, P O Box 34560, Groote Schuur 7937, Cape Town, South Africa
Am J Respir Crit Care Med 170:836-44. 2004..07-0.27 per patient per year) and improvement in health status were significantly better with salmeterol/fluticasone. This study confirms that the goal of guideline-derived asthma control was achieved in a majority of the patients...
Rate of response of individual asthma control measures varies and may overestimate asthma control: an analysis of the goal studyEric D Bateman
University of Cape Town, Cape Town, South Africa
J Asthma 44:667-73. 2007....
How appropriate is asthma therapy in general practice?Laurent Laforest
Pharmacoepidemiology Unit, EA 3091, CHU Lyon, France
Fundam Clin Pharmacol 19:107-15. 2005..Antibiotics, expectorants, antihistamines, antitussives and nasal corticosteroids were commonly prescribed while asthma controllers were under-used...
Montelukast and fluticasone compared with salmeterol and fluticasone in protecting against asthma exacerbation in adults: one year, double blind, randomised, comparative trialLeif Bjermer
Department of Respiratory Medicine and Allergology, University Hospital, SE-221 85 Lund, Sweden
BMJ 327:891. 2003..Both treatments were generally well tolerated. CONCLUSION: The addition of montelukast in patients whose symptoms remain uncontrolled by inhaled fluticasone could provide equivalent clinical control to salmeterol...
ARIA update: I--Systematic review of complementary and alternative medicine for rhinitis and asthmaGiovanni Passalacqua
Allergy and Respiratory Diseases, University of Genoa, Italy
J Allergy Clin Immunol 117:1054-62. 2006..There are also unresolved safety concerns. Therapeutic efficacy of complementary-alternative treatments for rhinitis and asthma is not supported by currently available evidence...
Improvement in asthma endpoints when aiming for total control: salmeterol/fluticasone propionate versus fluticasone propionate aloneAshley A Woodcock
North West Lung Centre, Wythenshawe Hospital, Manchester, UK
Prim Care Respir J 16:155-61. 2007..To investigate the magnitude of change in morning peak expiratory flow (PEF), asthma symptoms, and rescue beta2-agonist use, when the aim of treatment is to achieve guideline-defined control...
Determinants of response to fluticasone propionate and salmeterol/fluticasone propionate combination in the Gaining Optimal Asthma controL studySøren E Pedersen
Department of Pediatrics, University of Southern Denmark, Pediatric Research Unit, Kolding Hospital, Kolding, Denmark
J Allergy Clin Immunol 120:1036-42. 2007..Approximately two thirds of patients achieved well-controlled (WC) asthma, and one third continued to have asthma that was not well controlled (NWC)...
Written information plans for patients receiving immunotherapyJean Bousquet
Ann Allergy Asthma Immunol 91:423-4. 2003
Influence of patients' characteristics and disease management on asthma controlLaurent Laforest
Pharmacoepidemiology Unit, EA3091, Lyon, France
J Allergy Clin Immunol 117:1404-10. 2006..A regular use of fixed controller combinations, helping patients to quit smoking, or addressing weight issues might contribute to improvement in asthma control...
Synergistic effects of fluticasone propionate and salmeterol on in vitro T-cell activation and apoptosis in asthmaElisabetta Pace
Istituto di Biomedicina e Immunologia Molecolare, Consiglio Nazionale delle Richerche, Via Ugo La Malfa 153, 90146 Palermo, Italy
J Allergy Clin Immunol 114:1216-23. 2004..In asthma T cells are characterized by an increased activation state and by reduced apoptosis...
Levocetirizine improves health-related quality of life and health status in persistent allergic rhinitisG Walter Canonica
Allergy and Respiratory Diseases Clinic, DIMI, Genoa University, Pad Maragliano, L go R Benzi 10, 16132 Genoa, Italy
Respir Med 100:1706-15. 2006..Allergic rhinitis is a chronic respiratory disorder with a detrimental impact on health-related quality of life (HRQOL) and health status. Enhancement and maintenance of patient function and well-being are therefore considered as essential...
Clustering patterns of LOD scores for asthma-related phenotypes revealed by a genome-wide screen in 295 French EGEA familiesEmmanuelle Bouzigon
1INSERM EMI0006, Evry, France
Hum Mol Genet 13:3103-13. 2004..These results provide new insights into the potential sharing of genetic determinants by asthma-related phenotypes...
Epidemiologic study of the genetics and environment of asthma, bronchial hyperresponsiveness, and atopyFrancine Kauffmann
Epidemiology and Biostatistics, , Villejuif, France
Chest 121:27S. 2002
Automated SNP detection from a large collection of white spruce expressed sequences: contributing factors and approaches for the categorization of SNPsNathalie Pavy
Forest Genomics, Pavillon Charles Eugène Marchand, Universite Laval, Ste Foy, Quebec G1K 7P4, Canada
BMC Genomics 7:174. 2006..As a first step toward this goal, we aimed to develop a resource of candidate Single Nucleotide Polymorphisms (SNP) in white spruce (Picea glauca [Moench] Voss), a softwood tree of major economic importance...
Diverging patterns of mitochondrial and nuclear DNA diversity in subarctic black spruce: imprint of a founder effect associated with postglacial colonizationIsabelle Gamache
, , Sainte-Foy, QC, Canada, G1K 7P4
Mol Ecol 12:891-901. 2003....
Global integrated guidelines are needed for respiratory diseasesJean Bousquet
Prim Care Respir J 15:10-2. 2006
Pulmonary hypertension: from an orphan disease to a public health problemMarc Humbert
Chest 132:365-7. 2007
Persistent activation of nuclear factor-kappaB signaling pathway in severe uncontrolled asthmaRosalia Gagliardo
Istituto di Biomedicina e Immunologia Molecolare, Consiglio Nazionale delle Ricerche, Palermo, Via Ugo La Malfa 153, 90146 Palermo, Italy
Am J Respir Crit Care Med 168:1190-8. 2003..Our data suggest that exaggerated NF-kappaB activation perpetuates inflammatory mediators production in severe asthma...
Positioning of glucocorticosteroids in asthma and allergic rhinitis guidelines (versus other therapies)Guy F Joos
Department of Respiratory Diseases, Ghent University Hospital, De Pintelaan 185, B 9000 Ghent, Belgium
Immunol Allergy Clin North Am 25:597-612, vii-viii. 2005..Intranasal corticosteroids are given as first-line therapy for moderate to severe persistent rhinitis. Depending on the dominant symptom, H1-antihistamines, decongestants, or ipratropium can be added after re-evaluation...
[Allergic rhinitis and its impact on asthma update (ARIA 2008). The Turkish perspective]Arzu Yorgancioglu
Department of Chest Diseases, Faculty of Medicine, Celal Bayar University, Manisa, Turkey
Tuberk Toraks 56:224-31. 2008..In this article, it is aimed to summarize the newly updated and published version of "Allergic Rhinitis and its Impact on Asthma (ARIA) 2008" and add the recent Turkish epidemiological data on it...
Noninvasive methods for the detection of upper and lower airway inflammation in atopic childrenMirella Profita
Institute of Biomedicine and Molecular Immunology, Section of Immunopathology and Clinical and Experimental Pharmacology of the Respiratory System, Italian National Research Council, Palermo, Italy
J Allergy Clin Immunol 118:1068-74. 2006..Exhaled nitric oxide (FE(NO)) and exhaled breath condensate (EBC) are noninvasive methods to assess inflammation...
Montelukast for treating fall allergic rhinitis: effect of pollen exposure in 3 studiesPaul Chervinsky
New England Research Center, North Dartmouth, Massachusetts, USA
Ann Allergy Asthma Immunol 92:367-73. 2004..CONCLUSIONS: Montelukast significantly improved daytime nasal symptoms score in patients with seasonal allergic rhinitis, and the effect was greater in patients exposed to higher pollen levels...
Molecular genetic diversity of the French-American grapevine hybrids cultivated in North AmericaPatrick Pollefeys
, , , Sainte-Foy, Canada
Genome 46:1037-48. 2003..vinifera. Two Kulhmann varieties thought to be synonymous were found to be different, though closely related...
Clinical and biological heterogeneity in children with moderate asthmaStefania La Grutta
Istituto di Medicina Generale e Pneumologia, , Via Trabucco 180, 90146 Palermo, Italy
Am J Respir Crit Care Med 167:1490-5. 2003....
